Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Actimid-d4; 4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione-d4
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for complete information
Pomalidomide-d4 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Pomalidomide-d4 usage and description
Pomalidomide D4 is a deuterated derivative of Pomalidomide, a medication used in the treatment of multiple myeloma. Pomalidomide D4 is a selective inhibitor of the enzyme cereblon, which is involved in the degradation of certain proteins within the body. By inhibiting cereblon, Pomalidomide D4 helps to reduce the levels of abnormal cells in the body, leading to a reduction in the symptoms of multiple myeloma.
Pomalidomide D4 is administered orally, typically in the form of a capsule. The dosage and duration of treatment depend on the individual patient's condition, response to treatment, and other factors that affect treatment efficacy.
In terms of chemical information, Pomalidomide D4 has a molecular formula of C13H3D4N4O3 and a molecular weight of 272.32 g/mol. It is a deuterated derivative of Pomalidomide, with four deuterium atoms replacing hydrogen atoms in the molecule. The deuterium substitution enhances the stability and pharmacokinetic properties of the molecule, leading to improved therapeutic efficacy.
Overall, Pomalidomide D4 is an important medication in the treatment of multiple myeloma, with proven efficacy and a well-established safety profile. It is important to consult with a healthcare professional before starting or changing any medication regimen.
